Description

BEMPETOL EZ TAB is a powerful lipid-lowering combination therapy that includes Bempedoic Acid and Ezetimibe, formulated to significantly reduce LDL-C (bad cholesterol) in adults with primary hyperlipidemia, heterozygous familial hypercholesterolemia, or patients at high cardiovascular risk.

Bempedoic Acid is an ATP citrate lyase inhibitor that works in the liver to decrease cholesterol production, while Ezetimibe inhibits cholesterol absorption in the intestines. Together, this dual-action combination provides:

• Greater LDL-C reduction than either agent alone

• A non-statin alternative for statin-intolerant patients

• Synergistic effects when combined with statins for severe cases

BEMPETOL EZ TAB is ideal for patients who:

• Cannot tolerate high-dose statins

• Need additional LDL-C control despite being on statins

• Are at increased risk of atherosclerosis or heart disease

Manufactured in WHO-GMP and ISO-certified facilities, BEMPETOL EZ TAB is represented by BLUEPILL EXPRESS, a globally trusted exporter of certified pharmaceutical medicines. With export capabilities across Asia, Africa, Europe, the Middle East, and North America, BLUEPILL EXPRESS ensures quality, documentation support, and on-time global delivery.

Use of this product should always be guided by a licensed physician, alongside dietary changes and lifestyle improvements for optimal cholesterol management.